content

Cellipont Bioservices has signed an agreement with Diakonos Oncology for the development of DOC1021, a cell therapy to treat glioblastoma multiforme (GBM). The parties will...

Cryoport, Inc. , a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of...

Cold Chain Technologies, LLC, a leading provider of thermal packaging solutions for the transportation of temperature-sensitive products for the life sciences industry, announced it...

Sygnature Discovery, a world-leading integrated drug discovery provider and non-clinical solutions provider, has announced a scientific collaboration with human induced pluripotent stem cell (iPSC)...

Elsevier, a global leader in information and data analytics, has launched the new PharmaPendium, sharpening the translational view of a platform that combines extensive preclinical...

Phastar, a global specialist biometrics contract research organization (CRO), has had its net-zero target approved by the Science Based Targets initiative (SBTi). The SBTi...

All drug manufacturers responsible for manufacturing the 10 prescription medicines that will be subject to the inaugural price negotiations for the U.S. Medicare health...